GlycoMimetics Inc.

NASDAQ: GLYC · Real-Time Price · USD
15.71
-0.44 (-2.72%)
At close: Jul 02, 2025, 3:58 PM

GlycoMimetics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
10.72M 41.79M 47.87M 90.25M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a 757.91K 102.32K 2.15M
Receivables
136.58K 175.82K 144.02K 1.35K
Inventory
n/a n/a -144.4K -533.81M
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
11.09M 43.79M 50.71M 90.25M
Property-Plant & Equipment
n/a 767.83K 993.56K 1.95M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
n/a 1.53M 1.1M 4.09M
Total Assets
11.09M 45.32M 51.81M 94.35M
Account Payables
329.3K 868.12K 970.19K 2.11M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
66.84M n/a n/a n/a
Other Current Liabilities
-66M 2.96M n/a n/a
Total Current Liabilities
5.78M 6.84M 8.88M 11.82M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a 66.84K 1.89M 918.61K
Total Liabilities
5.78M 6.9M 8.88M 12.74M
Total Debt
66.84K 808.4K 918.55K 1.92M
Common Stock
64.48K 64.39K 54.38K 52.31K
Retained Earnings
-494.36B -456.49M -419.59M -372.9M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
5.31B 38.41M 42.93M 81.6M
Total Investments
10.71B n/a n/a n/a